Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
102.23
(
-2.11%
)
Bitcoin
70,560.00
(
0.95%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 68603

Saturday, 11/15/2008 3:04:34 PM

Saturday, November 15, 2008 3:04:34 PM

Post# of 257262
Re: Atripla quiz answer

>Chances are that a new drug will replace Sustiva in the Atripla combo even before it goes off patent in 2013 (that's when GILD will probably be ready with a generic version).<

Even if that were to happen, Atripla would not simply disappear and it would remain a very attractive target for genericization.

In other words, that’s an incorrect quiz answer, which is an uncommon sight for you :- )


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now